Caricamento...
Drug Development for Psychotropic, Cognitive Enhancing and Disease-Modifying Treatments for Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with limited available therapies. There is progress in developing treatments for neuropsychiatric indications including agitation, psychosis, apathy, and sleep disorders in AD. Candidate therapies progress from nonclinical/animal a...
Salvato in:
| Pubblicato in: | J Neuropsychiatry Clin Neurosci |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7989572/ https://ncbi.nlm.nih.gov/pubmed/33108950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.neuropsych.20060152 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|